Agios Pharmaceuticals, INC., a biopharmaceutical company pioneering therapies for
genetically defined diseases, with a near-term focus on developing therapies for
hemolytic anemias.
contact information
Jen Krone
Hemolytic Anemia Specialist
Jen.Krone@agios.com
630.452.400